Eli Lilly Wins the ImClone Prize
By Sally Mardikian PhD
Pharma Deals Review: Vol 2008 Issue 101 (Table of Contents)
Published: 6 Oct-2008
DOI: 10.3833/pdr.v2008.i101.123 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
Eli Lilly has become the proud owner of ImClone, successfully outbidding Bristol-Myers Squibb (BMS) and paying nearly US$2 B more than BMS’ original offer in the process...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS